Molecular and Cellular Neuroscience

Papers
(The TQCC of Molecular and Cellular Neuroscience is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells172
Operative list of genes associated with autism and neurodevelopmental disorders based on database review52
Models of the blood-brain barrier using iPSC-derived cells43
Norepinephrine and glucocorticoid effects on the brain mechanisms underlying memory accuracy and generalization42
Tcf4 is required for correct brain development during embryogenesis36
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models31
The impact of chronic stress on energy metabolism29
Molecular mechanisms of cell polarity in a range of model systems and in migrating neurons25
Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery24
Regulation of actin dynamics in dendritic spines: Nanostructure, molecular mobility, and signaling mechanisms24
Activation and functional modulation of satellite glial cells by oxaliplatin lead to hyperexcitability of sensory neurons in vitro23
Mechanotransduction in mammalian sensory hair cells23
Spatial control of membrane traffic in neuronal dendrites22
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells20
Molecular correlates of mitochondrial dysfunctions in major depression: Evidence from clinical and rodent studies20
P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease18
ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation18
Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration18
Leptin stimulates synaptogenesis in hippocampal neurons via KLF4 and SOCS3 inhibition of STAT3 signaling16
Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration16
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice16
The ubiquitin ligase UBE4B regulates amyloid precursor protein ubiquitination, endosomal trafficking, and amyloid β42 generation and secretion16
When glia meet induced pluripotent stem cells (iPSCs)16
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia16
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease16
Application of induced pluripotent stem cells in epilepsy16
LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease15
Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons15
Erythropoietin modulates striatal antioxidant signalling to reduce neurodegeneration in a toxicant model of Parkinson's disease14
Polyglutamine expanded Ataxin-7 induces DNA damage and alters FUS localization and function14
The dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production13
Animal models of hidden hearing loss: Does auditory-nerve-fiber loss cause real-world listening difficulties?13
The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain13
Overexpression of the vesicular acetylcholine transporter disrupts cognitive performance and causes age-dependent locomotion decline in Drosophila13
Presynaptic voltage-gated calcium channels in the auditory brainstem13
Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease12
Axonal spheroids in neurodegeneration12
Ketamine attenuates the PTSD-like effect via regulation of glutamatergic signaling in the nucleus accumbens of mice12
Pharmacologic treatments in preclinical tinnitus models with special focus on Ginkgo biloba leaf extract EGb 761®12
Effects of selective inhibition of nNOS and iNOS on neuropathic pain in rats12
Distinct subpopulations of D1 medium spiny neurons exhibit unique transcriptional responsiveness to cocaine12
Opioid receptor activation suppresses the neuroinflammatory response by promoting microglial M2 polarization12
The potential roles of excitatory-inhibitory imbalances and the repressor element-1 silencing transcription factor in aging and aging-associated diseases12
Cyclic regulation of Trpm4 expression in female vomeronasal neurons driven by ovarian sex hormones11
Nectins and Nectin-like molecules in synapse formation and involvement in neurological diseases11
Intermitochondrial signaling regulates the uniform distribution of stationary mitochondria in axons11
Synaptic transmission at the vestibular hair cells of amniotes11
Revealing NOTCH-dependencies in synaptic targets associated with Alzheimer's disease11
Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model10
Matrix metalloprotease-mediated cleavage of neural glial-related cell adhesion molecules activates quiescent olfactory stem cells via EGFR10
Identifying targets to prevent aminoglycoside ototoxicity10
Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE)10
Sympathomimetics regulate quantal acetylcholine release at neuromuscular junctions through various types of adrenoreceptors9
Postganglionic sympathetic neurons, but not locus coeruleus optostimulation, activates neuromuscular transmission in the adult mouse in vivo9
ALS, a cellular whodunit on motor neuron degeneration9
Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease9
CHRNA1 promotes the pathogenesis of primary focal hyperhidrosis9
BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation9
Dimethyl itaconate reprograms neurotoxic to neuroprotective primary astrocytes through the regulation of NLRP3 inflammasome and NRF2/HO-1 pathways9
Parvalbumin subtypes of cerebellar Purkinje cells contribute to differential intrinsic firing properties9
Amyloid-β precursor protein processing and oxidative stress are altered in human iPSC-derived neuron and astrocyte co-cultures carrying presenillin-1 gene mutations following spontaneous differentiati8
Memantine improves cognitive deficits via KATP channel inhibition in olfactory bulbectomized mice8
An integrative study of genetic variants with brain tissue expression identifies viral etiology and potential drug targets of multiple sclerosis8
Behavioral profiling reveals an enhancement of dentate gyrus paired pulse inhibition in a rat model of PTSD8
Ih, GIRK, and KCNQ/Kv7 channels differently modulate sharp wave - ripples in the dorsal and ventral hippocampus8
Role of induced pluripotent stem cells in lysosomal storage diseases8
Tip60 protects against amyloid-β-induced transcriptomic alterations via different modes of action in early versus late stages of neurodegeneration8
Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics8
Effect of germ-free status on transcriptional profiles in the nucleus accumbens and transcriptomic response to chronic morphine8
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease8
Plasticity of postsynaptic nanostructure8
Resilience to fear: The role of individual factors in amygdala response to stressors8
Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease8
0.018532991409302